Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infections.
Fink
M P
MP
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016905:Gram-Negative Bacterial Infections / Q000628:therapy*; D006801:Humans; D007075:Immunoglobulin M / Q000627:therapeutic use*; D007136:Immunoglobulins / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D018805:Sepsis / Q000628:therapy*
D000911:Antibodies, Monoclonal; D007075:Immunoglobulin M; D007136:Immunoglobulins; C042866:antilipopolysaccharide antibodies; C071470:edobacomab